⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Narrow Band Imaging for Diagnosis of Proximal Serrated Polyps

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Narrow Band Imaging for Diagnosis of Proximal Serrated Polyps

Official Title: Colonoscopy With Narrow Band Imaging for Diagnosis of Proximal Serrated Polyps

Study ID: NCT01725321

Interventions

Narrow band imaging

Study Description

Brief Summary: Although colonoscopy is considered the gold standard for diagnosis of colonic polyps, the missed rate for colonic adenoma ranged from 15-32%. In particular, missed colonic polyps in the right side colon have been suggested to be the cause for interval cancer that developed after a prior negative colonoscopy. Different endoscopic image enhanced modules like the narrow band imaging (NBI) have been developed to improve colonic polyp detection. However, it remains controversial whether the previous version of NBI helps to improve colonic polyp detection. The new generation colonoscope is equipped with high definition and improved narrow band imaging (NBI) which gives at least twice the viewable distance and contrast. The images obtained are far brighter with better resolution than the previous version. It however remains to be determined whether this enhanced imaging technique could help to improve colonic polyps detection. Hypothesis: The new generation NBI increases the detection rate of proximal serrated polyps and reduces the missed rate of all colorectal polyps. Aims: * To determine whether the new generation NBI improve the detection rate of proximal serrated polyps. * To determine whether the new generation NBI improve the detection rate of all colorectal adenoma and polyps. * To determine whether the new generation NBI reduce the miss rate of colorectal adenoma and polyps.

Detailed Description: Design: Prospective randomized trial Inclusion: • All patients scheduled to have screening or scheduled colonoscopy Exclusion: * History of Crohn's or ulcerative colitis * Surveillance for known polyposis syndrome (FAP or HNPCC) * Previous colonic resection (except appendectomy) * Refused consent * Deranged coagulation profile that preclude polypectomy

Eligibility

Minimum Age: 40 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: Yes

Locations

Queen Mary Hospital, Hong Kong, , China

Contact Details

Name: Wai Keung Leung, MD

Affiliation: The University of Hong Kong

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: